CROOKES BROTHERS LIMITED - Trading Statement for the six months ended 30 September 2026
What this filing means
Crookes Brothers expects interim basic EPS of 206.0 to 218.8 cents, 60% to 70% above the comparative period, but the filing notes that a Mozambican macadamia impairment reversal is excluded from HEPS. HEPS is guided down 88% to 98% to 2.4 to 15.0 cents as lower sugar cane earnings, depressed regional sugar prices and industrial action weigh on the segment. Improved banana performance provides only a partial offset, leaving the guidance pointing to severe underlying weakness.
The two earnings measures tell very different stories. Basic EPS is expected to improve, partly because a reversal of an earlier macadamia impairment is included in that measure but excluded from HEPS. HEPS is expected to collapse as low sugar prices and mill industrial action weaken the sugar cane segment; improved banana earnings only partly offset that pressure. These are preliminary, unaudited expectations, but if they hold, they point to a substantial deterioration in underlying profitability.
Bull case
- Basic EPS is expected to rise 60% to 70%, but the impairment reversal on the Mozambican macadamia operations is excluded from HEPS, explaining the divergence between the two measures.
- Improved banana-segment performance partially offset weaker sugar cane earnings during the interim period.
Bear case
- Headline earnings per share are expected to fall by between 88% and 98% to 2.4–15.0 cents, indicating a severe deterioration in underlying headline profitability.
- Sugar cane earnings declined as low-priced SACU imports depressed prices in South Africa and Eswatini.
- The filing provides no forward guidance or second-half outlook.
- The filing discloses no cash-flow or balance-sheet data to assess the financial consequences of weaker segment earnings.
AI-generated summary by SENS-AI, based on the original JSE SENS filing.
SENS-AI conclusion
The HEPS guidance suggests severe underlying weakness, even though basic EPS is expected to rise 60% to 70%. The filing indicates that an impairment reversal excluded from HEPS helps explain the divergence, while depressed sugar prices and industrial action weigh on sugar cane earnings; improved banana performance offers only a partial offset. This is a fresh negative interim disclosure rather than a benchmark miss, but its severity supports a bearish fundamental read if the guidance holds. So what: the 27 November interim results must confirm the HEPS range and show the cash and balance-sheet consequences.
The 27 November interim results are where the market will test whether operating cash flow and the balance sheet can absorb the sugar cane earnings collapse.
Evidence from the filing
Headline earnings per share are expected to fall by between 88% and 98% to 2.4–15.0 cents, indicating a severe deterioration in underlying headline profitability.
“• Headline earnings per share (“HEPS”) of between 2.4 cents and 15.0 cents per share (a decrease of between 98% and 88%, respectively, when compared to HEPS of 126.9 cents per share reported for the interim period ended 30 September 2025).”
Sugar cane earnings declined as low-priced SACU imports depressed prices in South Africa and Eswatini.
“Earnings from the sugar cane segment for the interim period were lower than the comparative period. Sugar cane prices in both South Africa and Eswatini were depressed by a surge in low-priced sugar imports into the SACU market.”
Missing evidence: the statement provides no second-half outlook and no cash-flow or balance-sheet data to assess the financial consequences of weaker segment earnings.
“The Company’s interim results for the period ended 30 September 2026 are expected to be published on or about 27 November 2026.”
Improved banana-segment performance partially offset weaker sugar cane earnings during the interim period.
“These factors were partially offset by an improved performance from the banana segment.”
Basic EPS is expected to rise 60% to 70%.
“• Basic earnings per share (“EPS”) of between 206.0 cents and 218.8 cents per share (an increase of between 60% and 70%, respectively, when compared to EPS of 128.4 cents per share reported for the interim period ended 30 September 2025); and”
The impairment reversal is excluded from HEPS, explaining the divergence between the two measures.
“Additionally, a reversal of a portion of the impairment recognised in prior financial years, in respect of the Group’s Mozambican macadamia operations, was processed following the classification of these operations as held for sale. This impairment reversal is excluded from the determination of headline earnings.”
More on Crookes Brothers Limited
Related filings
More from CKS
- CROOKES BROTHERS LIMITED - Resignation of Company Secretary
- CROOKES BROTHERS LIMITED - Notice of Provision of Direct or Indirect Financial Assistance in terms of Section 45 of the Companies Act No 71 of 2008
- CROOKES BROTHERS LIMITED - Proposed Disposal of Murrimo Macadamia Limitada and Murrimo Farming Limitada and Withdrawal of Cautionary Announcement
- CROOKES BROTHERS LIMITED - Results of the Annual General Meeting
- CROOKES BROTHERS LIMITED - Cautionary Announcement regarding the Potential Disposal of Murrimo Macadamia Limitada and Murrimo Farming Limitada